This September, for Gynecologic Cancer Awareness Month, we are spotlighting the innovative discoveries supported through GCI Internal Awards that are accelerating progress in research and care.
Meet Dr. Andrew Roth, Principal Investigator on the project, “Mapping the evolution of resistance to cytotoxic and non-cytotoxic chemotherapies in high grade serous ovarian cancer.” Dr. Andrew Roth’s work is supported through the Plunge for the Cure Grants (2024-2026).
GCI sincerely acknowledges the support of the Plunge for the Cure Foundation, through the VGH & UBC Hospital Foundation, for the Plunge for the Cure Grants.
As Gynecologic Cancer Awareness Month comes to a close, thank you for following along as we spotlighted the innovative discoveries supported through GCI Internal Awards that are accelerating progress in research and care.
Stay in the loop with the Gynecologic Cancer Initiative: